Building on research at Sussex, leading cancer researchers in the School of Life Sciences, Professor Georgios Giamas and Professor John Spencer launched Stingray Bio in 2021, to develop new therapies for breast cancers and potentially other cancer types. The new agreement with ValiRx is a big step in the path to commercialising new therapeutics for cancer patients.
Cancer treatment technology developed at Sussex to start preclinical tests
Previous
Previous
Dame Lesley presents at the UK Interdisciplinary Breast Cancer Symposium.
Next
Next